cytosine has been researched along with Prostatic Hyperplasia in 6 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Established prostate cancer-derived cell lines LnCAP, DU-145, and PC-3 demonstrated NQO1 wild-type genotype." | 1.30 | 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. ( Borkowsi, M; Hillenbrand, M; Schuff-Werner, P; Seiter, H; Steiner, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortese, R | 1 |
| Kwan, A | 1 |
| Lalonde, E | 1 |
| Bryzgunova, O | 1 |
| Bondar, A | 1 |
| Wu, Y | 1 |
| Gordevicius, J | 1 |
| Park, M | 1 |
| Oh, G | 1 |
| Kaminsky, Z | 1 |
| Tverkuviene, J | 1 |
| Laurinavicius, A | 1 |
| Jankevicius, F | 1 |
| Sendorek, DH | 1 |
| Haider, S | 1 |
| Wang, SC | 1 |
| Jarmalaite, S | 1 |
| Laktionov, P | 1 |
| Boutros, PC | 1 |
| Petronis, A | 1 |
| Steiner, M | 1 |
| Hillenbrand, M | 1 |
| Borkowsi, M | 1 |
| Seiter, H | 1 |
| Schuff-Werner, P | 1 |
| Tamada, H | 1 |
| Kitazawa, R | 1 |
| Gohji, K | 1 |
| Kitazawa, S | 1 |
| Shibata, A | 1 |
| Stamey, TA | 1 |
| McNeal, JE | 1 |
| Cheng, I | 1 |
| Peehl, DM | 1 |
| Bedford, MT | 1 |
| van Helden, PD | 1 |
6 other studies available for cytosine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Epigenetic markers of prostate cancer in plasma circulating DNA.
Topics: Aged; Biomarkers, Tumor; Case-Control Studies; Centromere; Chromosomes, Human, Pair 10; Cytosine; DN | 2012 |
609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Topics: Adenocarcinoma; Alleles; Cytosine; Female; Genes, Neoplasm; Genotype; Humans; Male; NAD(P)H Dehydrog | 1999 |
The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.
Topics: Adenine; Cytosine; Guanine; Humans; Male; Prostatic Hyperplasia; Receptors, Androgen; Trinucleotide | 1999 |
Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
Topics: Aged; Blotting, Northern; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 6; Bone Morphogen | 2001 |
Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement.
Topics: Adenine; Aged; Cholestenone 5 alpha-Reductase; Cytosine; Guanine; Humans; Male; Middle Aged; Oxidore | 2001 |
Hypomethylation of DNA in pathological conditions of the human prostate.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA; Humans; Male; Mathematics; Methylat | 1987 |